BioSpace News Archive

Kintor Pharma to Report 2021 Interim Financial Results and Host Conference Call on August 30, 2021

Kintor Pharmaceutical Limited, a clinical-stage biotechnology company developing innovative small molecule and biological therapeutics, announced the company will review the interim results and business highlights on Monday, August 30,2021.

August 24, 2021
·
1 min read
Bio NC

United Therapeutics to Present Tyvaso DPI™ BREEZE Clinical Data at the European Respiratory Society International Congress 2021

United Therapeutics Corporation announced it will present data from a clinical trial studying Tyvaso DPI™ in patients with pulmonary arterial hypertension at the European Respiratory Society International Congress 2021, which will be held virtually from September 5-8, 2021.

August 24, 2021
·
9 min read
Pharm Country

Seneca Therapeutics, Inc. Announces Issued U.S Patents for Tumor Endothelial Marker 8 (TEM8) Technology to Enable Better Patient Selection for SVV-001 Therapy

Seneca Therapeutics, Inc., a clinical-stage biopharmaceutical company dedicated to the development of oncolytic immune-therapeutics based on Seneca Valley Virus, announced the issuance and allowance of several U.S. patents for TEM8 licensed from Memorial Sloan Kettering Cancer Center.

August 24, 2021
·
3 min read
Biotech Beach

Pulmoheal™/ Artiveda™ Is Clinically Active Against Mild And Moderate Covid-19.

Oncotelic Therapeutics, Inc., a leading developer of TGF-β therapeutics for oncology and COVID-19, reported that PulmoHealTM/ ArtiVedaTM has proven active against mild and moderate COVID-19 following the preplanned prospective analysis of ARTI-19 clinical trial.

August 24, 2021
·
6 min read
Business

CTI BioPharma Announces Appointment of Diane Parks to Its Board of Directors

CTI BioPharma Corp. announced the appointment of Diane Parks to its Board of Directors.

August 24, 2021
·
6 min read
Business

Nacuity Pharmaceuticals Appoints Robert R. Ruffolo, Ph.D., to Board of Directors

Nacuity Pharmaceuticals today announced the appointment of Robert R. Ruffolo, Ph.D., to its Board of Directors.

August 24, 2021
·
2 min read
Drug Development

HCW Biologics Showcases Scientific Paper in Molecular Therapy Highlighting Potential of HCW9218 as Novel, Bifunctional Cancer Immunotherapeutic

HCW Biologics Inc. announced the publication of a scientific paper, authored by the Company’s scientific research team in the peer-reviewed journal, Molecular Therapy.

August 24, 2021
·
6 min read
Genetown

Stealth BioTherapeutics Submits Elamipretide New Drug Application to FDA for Treatment of Barth Syndrome

Stealth BioTherapeutics Corp today announced the submission of a New Drug Application (NDA) to the U.S. Food and Drug Adminstration (FDA) for elamipretide, the company’s lead product candidate, for the treatment of Barth syndrome, an ultra-rare genetic condition with no FDA- or EMA-approved therapies.

August 24, 2021
·
7 min read
Genetown

Solid Biosciences to Present at the 11th Annual World Orphan Drug Congress USA 2021

Solid Biosciences Inc. today announced that Joel Schneider, PhD, Chief Operating Officer, will discuss Solid’s robust, scalable approach to manufacturing AAV gene therapy for Duchenne muscular dystrophy at the 11th Annual World Orphan Drug Congress USA 2021, on Friday, August 27, at 11:15 AM ET.

August 24, 2021
·
5 min read
Pharm Country

Newly Published Peer-Reviewed Study Shows Efficacy of Equashield CSTD in Preventing Hazardous Drug Contamination When Compounding Cytotoxic Medications in Real-World Setting

Equashield (equashield.com), a leading provider of Closed System Transfer Devices (CSTDs) for hazardous drugs, today announced the publication of a peer-reviewed study proving the effectiveness of its CSTD in eliminating leakage of hazardous materials when compounding antineoplastic drugs.

August 24, 2021
·
3 min read